4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-26-000094
Chief Medical Officer sold 14,474 shares at an average $24.19 ($350,087)
- Chief Medical Officer acquired 8,126 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/wk-form4_1781745485.xml…